In Vitro Chemoresistance and Chemosensitivity Assays
This policy defines Blue Cross Blue Shield - Oklahoma's reimbursement stance for in vitro chemosensitivity and chemoresistance assays and lists related procedure codes; it applies to providers submitting claims to BCBSOK for these assays.
Added code 0525U.
Deleted code 0564T.
Document updated with literature review; reimbursement information unchanged.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.